Epigenetics in Medullary Thyroid Cancer: From Pathogenesis to Targeted Therapy

E-ISSN： 2212-3970|11|3|275-282

ISSN： 1574-8928

Source： Recent Patents on Anti-Cancer Drug Discovery, Vol.11, Iss.3, 2016-08, pp. : 275-282

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Medullary and non-medullary thyroid cancer in a family

By Ardern-jones Audrey Harvey Roderick J. Wilson Philip Sharma Anup K. Murday Vicky Harmer Clive Houlston Richard S.

Acta Oncologica, Vol. 43, Iss. 7, 2004-10 ,pp. : 680-681

Informa Healthcare

Access to resources Recommend Favorite

Medullary Thyroid Cancer: Are Practice Patterns in the United States Discordant From American Thyroid Association Guidelines?

By Panigrahi Babita

Annals of Surgical Oncology, Vol. 17, Iss. 6, 2010-06 ,pp. : 1490-1498

Springer Publishing Company

Access to resources Recommend Favorite

Targeted therapy in refractory thyroid cancer: current achievements and limitations

By Brilli Lucia Pacini Furio

Future Oncology, Vol. 7, Iss. 5, 2011-05 ,pp. : 657-668

Future Medicine

Access to resources Recommend Favorite

Molecular pathogenesis of thyroid cancer

By Segev D.L. Umbricht C. Zeiger M.A.

Surgical Oncology, Vol. 12, Iss. 2, 2003-08 ,pp. : 69-90

Elsevier

Access to resources Recommend Favorite

Medullary thyroid carcinoma: The third most common thyroid cancer reviewed

By Stamatakos Michael Paraskeva Panoraia Stefanaki Charikleia Katsaronis Paraskevas Lazaris Andreas Safioleas Konstantinos Kontzoglou Konstantinos

Oncology Letters, Vol. 2, Iss. 1, 2011-01 ,pp. : 49-53

Spandidos Publications

Access to resources Recommend Favorite